Allopregnanolone effects on short term memory
- Conditions
- Healthy women 35-40 years of age
- Registration Number
- EUCTR2005-005565-10-SE
- Lead Sponsor
- ppsala University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Authorised-recruitment may be ongoing or finished
- Sex
- Female
- Target Recruitment
- Not specified
Inclusion Criteria
Age 35-40.
Physically healthy according to medical history, examination and routine blood chemistry.
Informed consent
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
Chronic disorder requiring daily medication.
Ongoing depressive- and/or anxiety disorder
Smoking > 5 cigarettes/day
Known or suspected disorder affecting memory
Ongoing treatment with any hormonal compound
Ongoing treatment with any CNS-active compound
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Main Objective: To evaluate allopregnanolone effect on short term memory.;Secondary Objective: ;Primary end point(s): Test battery for episodic memory<br>Test battery for semantic memory<br>Test battery for executive functions (N-back)
- Secondary Outcome Measures
Name Time Method